Maintenance decitabine (DAC) improves disease-free (DFS) and overall survival (OS) after intensive therapy for acute myeloid leukemia (AML) in older adults, particularly in FLT3-ITD-negative patients: ECOG-ACRIN (E-A) E2906 randomized study Meeting Abstract
| Authors: | Foran, J. M.; Sun, Z.; Claxton, D. F.; Lazarus, H. M.; Arber, D. A.; Rowe, J. M.; Paietta, E.; Racevskis, J.; Altman, J. K.; Luger, S. M.; Al-Kali, A.; Zheng, H.; Pratz, K. W.; Broun, E. R.; Powell, B. L.; O'Dwyer, K. M.; Godwin, J. E.; Ofran, Y.; Litzow, M.; Tallman, M. S. |
| Abstract Title: | Maintenance decitabine (DAC) improves disease-free (DFS) and overall survival (OS) after intensive therapy for acute myeloid leukemia (AML) in older adults, particularly in FLT3-ITD-negative patients: ECOG-ACRIN (E-A) E2906 randomized study |
| Meeting Title: | 61st Annual Meeting and Exposition of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 134 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2019 Dec 7-10 |
| Meeting Location: | Orlando, FL |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2019-11-13 |
| Start Page: | 115 |
| Language: | English |
| ACCESSION: | WOS:000518218500445 |
| DOI: | 10.1182/blood-2019-129876 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 615 -- Source: Wos |
